InvestorsHub Logo
Followers 6
Posts 242
Boards Moderated 0
Alias Born 03/24/2010

Re: doggone post# 45613

Thursday, 07/29/2010 2:11:39 PM

Thursday, July 29, 2010 2:11:39 PM

Post# of 58002
If it is exclusive, then yes, that one company will be the sole provider to the school health market. However, if you read the PR, this sales agreement is for the VersaTemp+ thermo, the professional medical field version, not the retail 5 in 1, thermo. Two different markets.

It's just a piece of the pie. They haven't even tapped into the Professional Doctor's Offices/Hospitals market yet.

As far as the failure of the previous retail version at Walgreens, again, we can't base the future sales on a failed previous one. Apple failed miserably 15 years ago with their first attempt at a tablet computer with the Newton, and creamed a home run with the development of another one this year in the iPad.

We also can't base future sales based on the previous sales team. The previous products weren't being directed by Marc Massoglia. He was only hired in January, and he has a very impressive resume in sales.

So far, this company is right on schedule for what they have planned for this year.

A) Transform company from primarily a distributor to a manufacturer
B) Develop and manufacture (in China) NEW products based on patent technology bought within the past few years.
C) Organize new sales and marketing team (by hiring Massoglia)
D) Showcase prototypes at trade shows and through sales team in US, Europe and Asia.
E) Become fully reporting and file for OTB uplisting
F) Signed exclusive US distributor agreement with Italian company Mebby
F) Redesign websites into Web 2.0 design for better ecommerce
G) Have everything ready to hit the market by late summer before flu season


IMO, this looks NOTHING like the standard pump and dump Pinkie scam company. This looks like a real company, trying to sell real products. They have struggled the past few years as they searched for a profitable business model, but they might have one now. IF they can generate enough sales to sustain themselves and grow, this will pay some huge dividends for those that are willing to risk some capital investing in it now. I would say we are sitting at that risk cusp right now. The future of this company is now dependent on how sales go after the new products and marketing go into effect in a month or two.

I'm willing to put up some risk capital and give them and their products a chance. It's money I can afford to lose. How about you? What's your risk level with this company?